
Reset all filters
01 7IgG/Hyaluronidase,Recombinant
Reset all filters
01 112900285
02 113274615
03 113647939
04 113800573
05 114122314
06 115428488
07 117372309.84
Reset all filters
01 12017
02 12018
03 12019
04 12020
05 12021
06 12022
07 12023
Company : Baxalta US Inc.
IgG/Hyaluronidase,Recombinant
Drug Cost (USD) : 17,372,310
Year : 2023
Prescribers : 203
Prescriptions : 2570
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Baxalta US Inc.
IgG/Hyaluronidase,Recombinant
Drug Cost (USD) : 15,428,488
Year : 2022
Prescribers : 191
Prescriptions : 2370
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Baxalta US Inc.
IgG/Hyaluronidase,Recombinant
Drug Cost (USD) : 13,274,615
Year : 2021
Prescribers : 179
Prescriptions : 2080
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Baxalta US Inc.
IgG/Hyaluronidase,Recombinant
Drug Cost (USD) : 13,647,939
Year : 2020
Prescribers : 193
Prescriptions : 2324
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Baxalta US Inc.
IgG/Hyaluronidase,Recombinant
Drug Cost (USD) : 13,800,573
Year : 2019
Prescribers : 211
Prescriptions : 2473
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Baxalta US Inc.
IgG/Hyaluronidase,Recombinant
Drug Cost (USD) : 14,122,314
Year : 2018
Prescribers : 221
Prescriptions : 2778
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Baxalta US Inc.
IgG/Hyaluronidase,Recombinant
Drug Cost (USD) : 12,900,285
Year : 2017
Prescribers : 200
Prescriptions : 2582
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF